Another characteristic used to evaluate
hepatocyte models is the presence of functional alpha -1-antitrypsin (α1AT), a protease inhibitor produced in the liver.
Not exact matches
Gandhi's research team is the first to develop a mouse
model with depleted levels of a protein called augmenter of liver regeneration (ALR), which is essential for the survival of liver cells called
hepatocytes.
To validate their computer
modeling predictions, researchers performed experiments in human cancer cell lines, mouse liver samples and primary human
hepatocytes.
«Investigators have been developing in - vitro liver
models for 40 years, but all of those systems ignore the distinct patterns of metabolically active
hepatocytes that exist within the liver sinusoid» says Martin Yarmush, MD, PhD, director of the MGH - CEM and the paper's senior author.
«Liver tissue
model accurately replicates
hepatocyte metabolism, response to toxins: Microfluidic device may help predict toxic effects of new drugs, study liver disease.»
However, Takebe's liver bud has the advantage of being grown from iPS cells, rather than, for example, the primary human
hepatocytes used in Bhatia's graft, which could make it useful in
modelling rare diseases or examining the specific genetic backgrounds of the iPS cell donors.
Human primary
hepatocytes and immortalized cell lines (e.g., HepaRG) are used to study these disorders, but due to these cells» high variability, low availability, short assay window, or lack of physiological relevance, researchers studying metabolic diseases are searching for more robust and reliable
models.
Rat
Hepatocyte Culture
Model of Macrosteatosis: Effect of Macrosteatosis Induction and Reversal on Viability and Liver - specific Function.
Currently, primary
hepatocytes are the most common cell
model, but their utility is fundamentally constrained by the substantial variation between donors and the finite number of cells that are harvestable from each donor.
However, hiPS cell - derived
hepatocytes are only useful as an in vitro
model system and for gene editing applications if they recapitulate critical
hepatocyte functions.
Currently, primary
hepatocytes are the most common cell
model, but their utility is constrained by large variation between donors and a finite number of cells harvestable from each donor.
Here, we present data demonstrating the suitability of these hiPS cell - derived
hepatocytes for
modeling the role of
hepatocytes in metabolic disorders.
Explains Verma, «This robust
model system opens the door to utilize human
hepatocytes for purposes that were previously impossible.
Taken together, these results demonstrated that disease - specific human iPS cell — derived
hepatocytes are capable of
modeling key pathological feature of A1ATD in vitro and may also prove useful for future drug screening assays.